Research ArticleArticle
High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen and Outi Mäkitie
The Journal of Rheumatology October 2014, jrheum.131107; DOI: https://doi.org/10.3899/jrheum.131107
Kati P. Markula-Patjas
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Kaisa K. Ivaska
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Minna Pekkinen
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Sture Andersson
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Eeva Moilanen
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Heli T. Viljakainen
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Outi Mäkitie
From the Pediatric Research Center, University of Tampere and Tampere University Hospital, Tampere; Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku, Turku; Folkhälsan Research Center; Children’s Hospital, Helsinki University Central Hospital and University of Helsinki, Helsinki; The Immunopharmacology Research Group, University of Tampere School of Medicine, Tampere, Finland. Supported by research funds from the Rheumatism Foundation Hospital, Helsinki University Central Hospital and Tampere University Hospital, The Finnish Foundation for Pediatric Research, the Academy of Finland, the Sigrid Jusélius Foundation, the Folkhälsan Research Foundation, and the Orion-Farmos Research Foundation, Finland. The funders had no role in data collection, analysis, or reporting. K.P. Markula-Patjas, MD, Pediatric Research Center, University of Tampere and Tampere University Hospital; K.K. Ivaska, PhD, Department of Cell Biology and Anatomy, Institute of Biomedicine, University of Turku; M. Pekkinen, PhD, Folkhälsan Research Center; S. Andersson, MD, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; E. Moilanen, MD, PhD, The Immunopharmacology Research Group, University of Tampere School of Medicine and Tampere University Hospital; H.T. Viljakainen, PhD, Children’s Hospital, Helsinki University Central Hospital and University of Helsinki; O. Mäkitie, MD, PhD, Folkhälsan Research Center, and Children’s Hospital, Helsinki University Central Hospital and University of Helsinki. Address correspondence to Dr. K.P. Markula-Patjas, Pediatric Research Center, University of Tampere and Tampere University Hospital, P.O. BOX 2000, 33521 Tampere, Finland. E-mail: kati.markula-patjas@pshp.fi. Accepted for publication August 1, 2014.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen, Outi Mäkitie
The Journal of Rheumatology Oct 2014, jrheum.131107; DOI: 10.3899/jrheum.131107
High Adiposity and Serum Leptin Accompanied by Altered Bone Turnover Markers in Severe Juvenile Idiopathic Arthritis
Kati P. Markula-Patjas, Kaisa K. Ivaska, Minna Pekkinen, Sture Andersson, Eeva Moilanen, Heli T. Viljakainen, Outi Mäkitie
The Journal of Rheumatology Oct 2014, jrheum.131107; DOI: 10.3899/jrheum.131107